Mark Barnett has cut some of former manager Neil Woodford's favourite holdings in the £1.4bn Edinburgh investment trust, adding 14 new stocks since the beginning of the year.
The manager has cut positions in AstraZeneca, BT Group, Capita, GlaxoSmithKline and ReckittBenckiser, and has made new investments in Babcock International, Beazley, BP, Brown (N), CLS, Compass, Derwent...
Risk to retail investors
Latest news and analysis
Taking up non-exec role
Following 2016 thematic review